The BIEL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIEL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BIEL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BIEL Detailed Price Forecast - CNN Money||View BIEL Detailed Summary - Google Finance|
|View BIEL Detailed Summary - Yahoo! Finance||View BIEL Stock Research & Analysis - Zacks.com|
|View BIEL Trends & Analysis - Trade-Ideas||View BIEL Major Holders - Barrons|
|View BIEL Call Transcripts - NASDAQ||View BIEL Breaking News & Analysis - Seeking Alpha|
|View BIEL Annual Report - CompanySpotlight.com||View BIEL OTC Short Report - OTCShortReport.com|
|View BIEL Fundamentals - TradeKing||View BIEL SEC Filings - Bar Chart|
|View Historical Prices for BIEL - The WSJ||View Performance/Total Return for BIEL - Morningstar|
|View the Analyst Estimates for BIEL - MarketWatch||View the Earnings History for BIEL - CNBC|
|View the BIEL Earnings - StockMarketWatch||View BIEL Buy or Sell Recommendations - MacroAxis|
|View the BIEL Bullish Patterns - American Bulls||View BIEL Short Pain Metrics - ShortPainBot.com|
|View BIEL Stock Mentions - StockTwits||View BIEL Stock Mentions - PennyStockTweets|
|View BIEL Stock Mentions - Twitter||View BIEL Investment Forum News - Investor Hub|
|View BIEL Stock Mentions - Yahoo! Message Board||View BIEL Stock Mentions - Seeking Alpha|
|View Insider Transactions for BIEL - SECform4.com||View Insider Transactions for BIEL - Insider Cow|
|View BIEL Major Holdings Summary - CNBC||View Insider Disclosure for BIEL - OTC Markets|
|View Insider Transactions for BIEL - Yahoo! Finance||View Institutional Holdings for BIEL - NASDAQ|
|View BIEL Stock Insight & Charts - FinViz.com||View BIEL Investment Charts - StockCharts.com|
|View BIEL Stock Overview & Charts - BarChart||View BIEL User Generated Charts - Trading View|
BioElectronics Corporation’s President Andy Whelan Joins Everett Jolly on “Stock Day” to Discuss Progress
Posted on Wednesday June 13, 2018
Uptick Newswire welcomed Andy Whelan, President of BioElectronics Corporation (OTC Pink:BIEL) (“the Company”) back onto the “Stock Day” podcast. Andy spoke with Everett about their progress in the US market, UK market, the new product, the US FDA, and new distributors and potential partnership opportunities. Allay® Menstrual Pain Therapy.
B. Braun Medical Includes BioElectronics ActiPatch Medical Device In Its Same Day Knee and Hip Surgical Program
Posted on Thursday May 31, 2018
FREDERICK, MD., May 31, 2018-- BioElectronics Corporation, maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed development of its same day surgical TOTAL ...
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
Posted on Tuesday May 29, 2018
While RecoveryRx is already US FDA cleared and available for treatment following eyelid surgery, the expanded market clearance would allow use by millions of Americans annually, who undergo a surgical procedure including hip and knee joint replacements and general surgery. RecoveryRx provides an adjunctive or alternative treatment to analgesics for postoperative pain and can reduce the need for opiate analgesics during postoperative recovery.
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application
Posted on Friday May 11, 2018
FREDERICK, MD, May 11, 2018-- BioElectronics Corporation, www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9 th, 2018 with the US Food and Drug Administration. ...